These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27427625)

  • 21. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
    Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
    J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-Assembled Upconversion Nanoparticle Clusters for NIR-controlled Drug Release and Synergistic Therapy after Conjugation with Gold Nanoparticles.
    Cai H; Shen T; Kirillov AM; Zhang Y; Shan C; Li X; Liu W; Tang Y
    Inorg Chem; 2017 May; 56(9):5295-5304. PubMed ID: 28402112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
    Li X; Xie C; Xia H; Wang Z
    Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of novel superparamagnetic Ni
    Qasim M; Asghar K; Dharmapuri G; Das D
    Nanotechnology; 2017 Sep; 28(36):365101. PubMed ID: 28675377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, photocatalytic and antimicrobial properties of SnO2, SnS2 and SnO2/SnS2 nanostructure.
    Fakhri A; Behrouz S; Pourmand M
    J Photochem Photobiol B; 2015 Aug; 149():45-50. PubMed ID: 26046748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functionalized nanoscale β-1,3-glucan to improve Her2+ breast cancer therapy: In vitro and in vivo study.
    Nasrollahi Z; Mohammadi SR; Mollarazi E; Yadegari MH; Hassan ZM; Talaei F; Dinarvand R; Akbari H; Atyabi F
    J Control Release; 2015 Mar; 202():49-56. PubMed ID: 25597638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering of pectin-capped gold nanoparticles for delivery of doxorubicin to hepatocarcinoma cells: an insight into mechanism of cellular uptake.
    Borker S; Pokharkar V
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):826-835. PubMed ID: 29749275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
    Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
    Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application.
    Teng X; Cheng S; Meng R; Zheng S; Yang L; Ma Q; Jiang W; He J
    J Nanosci Nanotechnol; 2015 May; 15(5):3773-9. PubMed ID: 26505004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chondroitin sulfate-capped super-paramagnetic iron oxide nanoparticles as potential carriers of doxorubicin hydrochloride.
    Mallick N; Anwar M; Asfer M; Mehdi SH; Rizvi MMA; Panda AK; Talegaonkar S; Ahmad FJ
    Carbohydr Polym; 2016 Oct; 151():546-556. PubMed ID: 27474599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery.
    An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment.
    Raikwar S; Vyas S; Sharma R; Mody N; Dubey S; Vyas SP
    AAPS PharmSciTech; 2018 Nov; 19(8):3839-3849. PubMed ID: 30280350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled co-release of doxorubicin and reactive oxygen species for synergistic therapy by NIR remote-triggered nanoimpellers.
    Hou B; Yang W; Dong C; Zheng B; Zhang Y; Wu J; Wang H; Chang J
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():94-102. PubMed ID: 28254338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
    Ding Y; Han J; Tian B; Han J; Zhang J; Zheng H; Han Y; Pei M
    Int J Pharm; 2014 Dec; 477(1-2):187-96. PubMed ID: 25455771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poly(ethylene glycol)-co-methacrylamide-co-acrylic acid based nanogels for delivery of doxorubicin.
    Kumar P; Behl G; Sikka M; Chhikara A; Chopra M
    J Biomater Sci Polym Ed; 2016 Oct; 27(14):1413-33. PubMed ID: 27383582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of diversified self-assembly systems based on a natural rosin-based tertiary amine for doxorubicin delivery and excellent emulsification.
    Lin HX; Yang MS; Tian C; Han CR; Song J; Duan JF; Jiang JX
    Colloids Surf B Biointerfaces; 2018 May; 165():191-198. PubMed ID: 29482130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter
    Cytryniak A; Żelechowska-Matysiak K; Nazaruk E; Bilewicz R; Walczak R; Majka E; Mames A; Bruchertseifer F; Morgenstern A; Bilewicz A; Majkowska-Pilip A
    Mol Pharm; 2022 Aug; 19(8):2818-2831. PubMed ID: 35849547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intimate contacted two-dimensional/zero-dimensional composite of bismuth titanate nanosheets supported ultrafine bismuth oxychloride nanoparticles for enhanced antibiotic residue degradation.
    Liu W; Dai Z; Liu Y; Zhu A; Zhong D; Wang J; Pan J
    J Colloid Interface Sci; 2018 Nov; 529():23-33. PubMed ID: 29879679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.